CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Is Sorafenib an acceptable treatment possibility for patients with advanced hepatocellular carcinoma?
DOI 10.1055/s-0031-1295961
Bibliografische Angaben
Nachweis in CareLit
Autor:innenD Bettinger, M Schultheiß, E Knüppel, R Thimme, HE Blum, HC Spangenberg
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide with an increasing incidence. For patients with advanced HCC Sorafenib is the treatment of choice since the SHARP study showed a survival benefit however daily clinical experience suggests that Sorafenib is much less effective than described in the SHARP study. Methods: Retrospectively, we analyzed 112 patients with advanced HCC treated w…
Zitieren
Zitierempfehlung
D Bettinger, M Schultheiß, E Knüppel, R Thimme, HE Blum, HC Spangenberg (2012) Is Sorafenib an acceptable treatment possibility for patients with advanced hepatocellular carcinoma?. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0031-1295961
Mit CareLit weiterarbeiten